This podcast episode explores the global health crisis of obesity and its economic implications. The prevalence of obesity worldwide is alarming, with projections indicating that over half of adults will be overweight or obese by 2035. The rising rates of obesity, coupled with increasing longevity, are placing a heavy burden on healthcare systems. The discussion focuses on the potential impact of anti-obesity drugs on healthcare and other industries, highlighting the promising results of the SELECT trial. The size of the obesity market is projected to reach between $55 billion and $144 billion by 2030, depending on the prevalence of obesity-related comorbidities and the availability of effective treatments.
